You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / CE

Transforming the Management of Rosacea in Skin of Color

  • Authors: Andrew F. Alexis, MD, MPH; Seemal R. Desai, MD; Susan C. Taylor, MD
  • CME / CE Released: 11/22/2019
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 11/22/2020
Start Activity


Target Audience and Goal Statement

This activity is intended for dermatologists, primary care physicians, obstetricians & gynecologists, and nurses.

The goal of this activity is to increase knowledge and competence regarding the special considerations in managing rosacea in patients with skin of color.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Underpinnings of rosacea
    • Efficacy and safety profiles of rosacea therapies
  • Have greater competence related to
    • Selecting from available and emerging rosacea therapies


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Faculty

  • Andrew F. Alexis, MD, MPH

    Professor of Dermatology
    Icahn School of Medicine
    Mount Sinai
    New York, New York

    Disclosures

    Disclosure: Andrew F. Alexis, MD, MPH, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Bausch Health Companies Inc.; Beiersdorf Inc.; Bristol-Myers Squibb Company; Celgene Corporation; Dermavant Sciences, Inc.; Galderma Laboratories, L.P.; LEO Pharma Inc.; L'Oreal; Menlo Therapeutics; Novartis Pharmaceuticals Corporation; Sanofi-Regeneron; UCB Pharma, Inc.; Unilever United States, Inc.; Valeant Pharmaceuticals International
    Received grants for clinical research from: Almirall Hermal GmbH; Bristol-Myers Squibb Company; Celgene Corporation; Galderma Laboratories, L.P.; LEO Pharma Inc.; Menlo Therapeutics; Novartis Pharmaceuticals Corporation; Valeant Pharmaceuticals International

  • Seemal R. Desai, MD, FAAD

    Founder, Innovative Dermatology, PA
    Immediate Past President, Skin of Color Society
    Clinical Assistant Professor
    Department of Dermatology
    University of Texas Southwestern Medical Center
    Dallas, Texas

    Disclosures

    Disclosure: Seemal R. Desai, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Almirall Hermal GmbH; Dermavant Sciences, Inc.; Galderma Laboratories, L.P.; Pfizer Inc.; SkinCeuticals
    Served as a speaker or a member of a speakers bureau for: Dermira Inc.; Pfizer Inc.
    Received grants for clinical research from: Symbio LLC; Watson Pharmaceuticals, Inc.

  • Susan C. Taylor, MD

    Associate Professor of Dermatology
    The Perlman School of Medicine University of Pennsylvania
    Philadelphia, Pennsylvania

    Disclosures

    Disclosure: Susan C. Taylor, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Galderma Laboratories, L.P.

Editor

  • Chris Washburn, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Chris Washburn, PhD has disclosed no relevant financial relationships.

Course Reviewer

  • Lynn McKinley-Grant, MD

    Skin of Color Society

    Disclosures

    Disclosure: Lynn McKinley-Grant, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Animlabs

CME, CE Reviewer / Nurse Planner

  • Hazel Dennison, DNP, RN, FNP, CPHQ, CNE

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Hazel Dennison, DNP, RN, FNP, CPHQ, CNE, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements

Developed through a collaboration between the Skin of Color Society and Medscape Education.



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Nurses

  • Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

Transforming the Management of Rosacea in Skin of Color

Authors: Andrew F. Alexis, MD, MPH; Seemal R. Desai, MD; Susan C. Taylor, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / CE Released: 11/22/2019

Valid for credit through: 11/22/2020

processing....

Educational Impact Challenge

The goal of this activity is to increase knowledge and competence regarding the special considerations in managing rosacea in patients with skin of color.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print